Published in Women's Health Weekly, March 27th, 1995
These approaches, all in various stages of clinical and preclinical testing, mark the advent of "smart medicine" in cancer treatment, said Patricia Steeg, Ph.D., Chief, Women's Cancers Section, U.S. National Cancer Institute (NCI). Unlike conventional chemotherapy, which relies on highly toxic drugs doing more damage to the tumor than to the patient, these new strategies use a form of "molecular judo," turning the tumor's own actions against itself.
"What's really amazing is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.